Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Dyne Therapeutics, Inc.(DYN) | 4,951,303 | 3,451,303 | -1,500,000 | $65.85M | $97.98M | 39.97% | +$32.13M |
| Entrada Therapeutics, Inc.(TRDA) | 4,425,784 | 4,425,784 | 0 | $66.79M | $62.71M | 25.58% | -$4.07M |
| iTeos Therapeutics, Inc. | 2,738,785 | 2,738,785 | 0 | $29.99M | $37.36M | 15.24% | +$7.37M |
| Werewolf Therapeutics, Inc.(HOWL) | 4,284,172 | 4,284,172 | 0 | $16.54M | $27.76M | 11.32% | +$11.22M |
| Repare Therapeutics, Inc. | 2,242,636 | 2,242,636 | 0 | $16.37M | $10.56M | 4.31% | -$5.81M |
| Adaptimmune Therapeutics plcADR(ADAPY) | 5,555,461 | 5,555,461 | 0 | $4.41M | $8.78M | 3.58% | +$4.37M |
| Harpoon Therapeutics, Inc. | 313,136 | 0 | -313,136 | $3.56M | $0 | — | -$3.56M |